ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 702338 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 702338; 2) Community: the network communities that were significantly associated with the response to NSC 702338; 3) Molecule: the relationships between components within communities and NSC 702338; 4) MDR: the compounds that were significantly associated with the NSC 702338.

NSC Compound Enrichment Correlation
NSC 656904 ANTINEOPLASTIC-656904 0.0102962192514438 0.075856364
NSC 679018 Null 0.0102962192514438 0.21283809
NSC 703174 Null 0.0102962192514439 0.25102774
NSC 720860 3,3'-dimethoxycarbonyl-5,5'-dimethyl-N,N-Bis(pyrazol-1-yl methyl)aniline 0.0102962192514439 0.45289179
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.0102962192514439 0.20359648
NSC 15200 WLN: GA N-O3*3 0.0107933723273943 0.080336441
NSC 347217 Carbamic acid, [5-amino-1,2-dihydro-3-(2-naphthalenyl)pyrido[3,4-b]pyrazin-7-yl]-, ethyl ester, monohydrochloride 0.0107933723273943 0.016111155
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0107933723273943 0.20345047
NSC 631451 Null 0.0107933723273943 0.37830693
NSC 650710 Null 0.0107933723273943 0.24376357
Total:70  Current:13    [First] [Prev] [Next] [Last]